| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.44 | 6e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |